Cognition Therapeutics, Inc. (CGTX): Sotuvga nisbatan narx
Cognition Therapeutics (CGTX) ishonchliligi miya degeneratsiyasiga qarshi kurashish uchun og'iz orqali qabul qilinadigan dori vositalarining tasdiqlanishi va grantlar ko'magiga asoslangan. GURU.Markets platformasi tomonidan taqdim etilgan kompaniyaning bozor kapitallashuvi va daromadlar nisbati aktivning dinamikasini tasdiqlaydi, bunda joriy daraja atrofida shakllangan. Biznes ustunligi sinapslarni tiklashda namoyon bo'ladi, mavjud likvidlik rezervini hisobga olgan holda, asosiy xavf klinika sinovlarining muvaffaqiyatiga bog'liq bo'lib qolmoqda.
Cognition Therapeutics (CGTX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Cognition Therapeutics, Inc.|CGTX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Cognition Therapeutics|CGTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Cognition Therapeutics|Tezkor likvidlik koeffitsiyenti cogrx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CGTX - Kompaniyaning sof foydasi|Forvard foyda Cognition Therapeutics|CGTX - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cognition Therapeutics, Inc.|CGTX - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Cognition Therapeutics, Inc.|CGTX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Cognition Therapeutics|CGTX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi cogrx.com|CGTX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Cognition Therapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:CGTX - cogrx.com
Uzoq muddatli pozitsiyani shakllantirishda xatarlarni minimallashtirish uchun, daromadning har bir dollari uchun to'langan premiumni aks ettiruvchi narx-savdo koeffitsiyentini tahlil qilish muhimdir. Cognition Therapeutics (CGTX) uchun joriy P/S baholash ko'rsatkichi shuni ko'rsatadiki, biznes qiymati maqsadli molekulalar uchun klinik sinovlarning muvaffaqiyati va FDA tasdig'iga bog'liq bo'lib, bu kompaniyaning neyrodegenerativ kasalliklar sektoridagi barqarorligini belgilaydi.
Cognition Therapeutics raqobatchilari
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati inhibikase.com (IKT)|Narxning daromadga nisbati Cassava Sciences Inc (SAVA)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
